Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02596542
Other study ID # METC 153038
Secondary ID
Status Completed
Phase N/A
First received November 3, 2015
Last updated August 1, 2016
Start date November 2015
Est. completion date May 2016

Study information

Verified date August 2016
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Interventional

Clinical Trial Summary

Cold-water immersion (CWI) is a frequently applied strategy to accelerate post-exercise recovery in both recreational as well as professional athletes. However, the effect of repeated post-exercise CWI on other recovery strategies remains unclear.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Males

- Aged between 18-35 years

- Healthy, recreationally active

- BMI < 25 kg/m2

- The ability to comply with the protocol (i.e. the set-up for the CWI is designed for subjects that are at least 1.70 m or taller).

Exclusion Criteria:

- Smoking

- Allergies to milk proteins (whey or casein)

- Female

- Arthritic conditions

- A history of neuromuscular problems

- Recent (<1 y) participation in amino acid tracer studies

- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).

- Individuals with GI diseases

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Post-exercise Cold Water Immersion

Intervention

Other:
Water immersion
Different temperatures of cold water immersion will be assessed

Locations

Country Name City State
Netherlands Maastricht University Maastricht Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle protein synthesis (expressed as fractional synthetic rate (FSR in %/h) 2 weeks No
Secondary Muscle temperature (expressed as degrees celsius) 1 day No
Secondary Glycogen concentration (expressed as micromol glycosol units*g dry wt) 1 day No